These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
307 related items for PubMed ID: 10874665
41. Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma. Takahashi Y, Oda Y, Kawaguchi K, Tamiya S, Yamamoto H, Suita S, Tsuneyoshi M. Mod Pathol; 2004 Jun; 17(6):660-9. PubMed ID: 15098008 [Abstract] [Full Text] [Related]
42. MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma. Ambros RA, Sheehan CE, Kallakury BV, Ross JS, Malfetano J, Paunovich E, Figge J. Mod Pathol; 1996 Dec; 9(12):1165-9. PubMed ID: 8972476 [Abstract] [Full Text] [Related]
43. Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas. Patterson H, Gill S, Fisher C, Law MG, Jayatilake H, Fletcher CD, Thomas M, Grimer R, Gusterson BA, Cooper CS. Br J Cancer; 1994 Jun; 69(6):1052-8. PubMed ID: 8198970 [Abstract] [Full Text] [Related]
44. MDM2 and CDK4 gene amplification in Ewing's sarcoma. Ladanyi M, Lewis R, Jhanwar SC, Gerald W, Huvos AG, Healey JH. J Pathol; 1995 Feb; 175(2):211-7. PubMed ID: 7738717 [Abstract] [Full Text] [Related]
45. Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas. Waber PG, Chen J, Nisen PD. Cancer Res; 1993 Dec 15; 53(24):6028-30. PubMed ID: 8261417 [Abstract] [Full Text] [Related]
46. Expression of p53 and mdm2 mRNA and protein in colorectal carcinomas. Broll R, Stark A, Windhövel U, Best R, Strik MW, Schimmelpenning H, Schwandner O, Kujath P, Bruch HP, Duchrow M. Eur J Cancer; 1999 Jul 15; 35(7):1083-8. PubMed ID: 10533452 [Abstract] [Full Text] [Related]
47. Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma. Park HR, Jung WW, Bertoni F, Bacchini P, Park JH, Kim YW, Park YK. Pathol Res Pract; 2004 Jul 15; 200(6):439-45. PubMed ID: 15310147 [Abstract] [Full Text] [Related]
49. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma. Soslow RA, Altorki NK, Yang G, Xie D, Yang CS. Mod Pathol; 1999 Jun 15; 12(6):580-6. PubMed ID: 10392633 [Abstract] [Full Text] [Related]
56. [Relationship between gastric cancer and gene amplification of p14 and mdm2]. Sun LP, Jiang NJ, Fu W, Xue YX, Zhao YS. Ai Zheng; 2004 Jan 15; 23(1):36-9. PubMed ID: 14720371 [Abstract] [Full Text] [Related]
57. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer. Ralhan R, Sandhya A, Meera M, Bohdan W, Nootan SK. Am J Pathol; 2000 Aug 15; 157(2):587-96. PubMed ID: 10934161 [Abstract] [Full Text] [Related]
58. p53 expression and relationship with MDM2 amplification in breast carcinomas. Buyukpinarbasili N, Gucin Z, Ersoy YE, İlbak A, Kadioglu H, Muslumanoglu M. Ann Diagn Pathol; 2016 Apr 15; 21():29-34. PubMed ID: 27040927 [Abstract] [Full Text] [Related]
59. p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma. Lim BH, Soong R, Grieu F, Robbins PD, House AK, Iacopetta BJ. Int J Cancer; 1996 Jun 21; 69(3):200-4. PubMed ID: 8682588 [Abstract] [Full Text] [Related]
60. Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP. Gomyo Y, Osaki M, Kaibara N, Ito H. Int J Cancer; 1996 May 29; 66(5):594-9. PubMed ID: 8647618 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]